Keywords: Biomarkers, biotechnology foresight, gene-centric human proteome project, nutriproteomics, personalized nutrition, population biobanks, prospective policy, proteogenomics, metabolome, Health technology assessment (HTA), Human Proteome Project (HPP), Human Genome Project (HGP), Human Proteome Organization (HUPO), mass spectrometry, Brain-to-Society (BtS), nanotechnology, biotechnology, Low and middle-income countries
Current Pharmacogenomics and Personalized Medicine
Title: Editorial (Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value)
Volume: 8 Issue: 4
Author(s): Vural Ozdemir, Jean Armengaud, Laurette Dube, Ramy Karam Aziz and Bartha M. Knoppers
Affiliation:
Keywords: Biomarkers, biotechnology foresight, gene-centric human proteome project, nutriproteomics, personalized nutrition, population biobanks, prospective policy, proteogenomics, metabolome, Health technology assessment (HTA), Human Proteome Project (HPP), Human Genome Project (HGP), Human Proteome Organization (HUPO), mass spectrometry, Brain-to-Society (BtS), nanotechnology, biotechnology, Low and middle-income countries
Export Options
About this article
Cite this article as:
Ozdemir Vural, Armengaud Jean, Dube Laurette, Karam Aziz Ramy and M. Knoppers Bartha, Editorial (Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value), Current Pharmacogenomics and Personalized Medicine 2010; 8 (4) . https://dx.doi.org/10.2174/187569210793368230
DOI https://dx.doi.org/10.2174/187569210793368230 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes
Current Pharmaceutical Design Immunotherapy for Prostate Cancer
Current Pharmaceutical Design Various Novel Erythromycin Derivatives Obtained by Different Modifications: Recent Advance in Macrolide Antibiotics
Mini-Reviews in Medicinal Chemistry Enantiospecific Synthesis of Heterocycles Linked to Purines: Different Apoptosis Modulation of Enantiomers in Breast Cancer Cells
Current Medicinal Chemistry Transcervical Oropharyngectomy: A Clinically Focused Review
Current Cancer Therapy Reviews The Role of Reactive Oxygen Species in Tumor Treatment and its Impact on Bone Marrow Hematopoiesis
Current Drug Targets Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine
Current Pharmaceutical Design Structure Based Drug Design and Molecular Docking Studies of Anticancer Molecules Paclitaxel, Etoposide and Topotecan using Novel Ligands
Current Drug Discovery Technologies Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Recent Patents on Anti-Cancer Drug Discovery p53 Targeting Can Enhance Cancer Therapy via Radiation, Heat and Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry The Role of Image Guided Radiotherapy in the Treatment of Soft Tissue Sarcoma
Current Cancer Therapy Reviews MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers
Current Pharmaceutical Design Protective Effect of Aspirin Against Oligomeric Aβ42 Induced Mitochondrial Alterations and Neurotoxicity in Differentiated EC P19 Neuronal Cells
Current Alzheimer Research Fluoroquinolones Prophylaxis of Bacterial Infections in Neutropenic Patients: Time to Re-Evaluate
Current Cancer Therapy Reviews Recent Advances in Chemical Genomics
Current Medicinal Chemistry Tumor Initiation in Human Malignant Melanoma and Potential Cancer Therapies
Anti-Cancer Agents in Medicinal Chemistry Adjuvant Zoledronic Acid Reduces Disease Recurrence in Breast Cancer: Antitumor Effects on the Seed and the Soil
Current Cancer Therapy Reviews Recent Developments in Taxane Drug Delivery
Current Drug Delivery